AzTrials
AzTrials

Mechanical Ventilation ComplicationP2 -RMCSNCT01479673

TICACOS International

A study testing Indirect Calorimetry measurement of Resting Energy Expenditure . in people with Mechanical Ventilation Complication, run by Rabin Medical Center at 1 site in Israel.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to perform a prospective, randomized, controlled blinded study in critically patients to assess the necessity for measuring daily resting energy expenditure as a guide for nutritional support. Our hypothesis is that tight caloric control will reduce the rate of new infections. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Mechanical Ventilation Complication
What is being tested?
Indirect Calorimetry measurement of Resting Energy Expenditure .
Could I receive a placebo?
No, everyone receives an active treatment
How many people
560 participants
Where
1 siteIsrael
Study dates
Nov 2011to Dec 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Mechanically-ventilated adults(Male or Female)admitted to general ICU within the first 48 hours of ICU admission.
  • Age ≥ 18 years;no upper age limit.
  • Expected stay in ICU> 3 days: [SAPS II (18) > ICU median or high-level of nursing care implemented or per clinical impression of attending physician]
  • Medical and abdomino/thoracic surgery patients, as well as multiple trauma patients with Glasgow Coma Score ≥ 10.

Who cannot join

  • Pregnancy.
  • DNR order.
  • Readmission in the ICU during the same hospitalization/transfer from other ICU.
  • Admission for postoperative monitoring.
  • Respiratory instability: SpO2 <90% or need for ventilator adjustments during the preceding hour or hyperventilation (Respiratory rate > 35/min)
  • Bicarbonate infusion, loss of bicarbonate (diarrhea, ureterosogmoidostomy or use of acetazoloamide, ultrafiltration).
Show all 15Show fewer
  • Aerosolization with nitric oxide or heliox, tracheal insufflations or visible leaks in chest drainage system.
  • FiO2 80% or patients requiring prone position
  • Chronic/acute liver failure:Child-Pugh class C
  • Brain injury for various reasons with Glasgow Coma Scale below 10.
  • Cardiac surgery patients.
  • Patients in the hospital for more than 7 days.
  • Contra indication to use enteral nutrition.
  • Participation in a clinical study with an investigational drug within one month prior to the start of this clinical trial.
  • Ethical issues that will influence subject eligibility.

Trial locations and contacts

1 site in 1 country.

Pierre Singer, MD,Professor contact

972-3-9376521

psinger@clalit.org.il

Milana Grinev, RN contact

972-3-9376521

milang@clalit.org.il

Israel1 site, 1 recruiting
  • Rabin Medical Center, Campus Beilinson

    Petah Tikva, Petach Tikva, 49100

    Pierre Singer, Professor,MD, 972-39376521, psinger@clalit.org.il

    Milana Grinev, Study Coordinator, 972-39376590, milang@clalit.org.il

    Recruiting

Other trials in Israel

About this study

Official title: Tight Caloric Balance in ICU Patients: a Multicenter, Prospective, Randomized, Controlled Study.

The aim of this study is to perform a prospective, randomized, controlled blinded study in critically patients to assess the necessity for measuring daily resting energy expenditure as a guide for nutritional support. Our hypothesis is that tight caloric control will reduce the rate of new infections.

Study Design :Multi-center, randomized, single blinded, controlled study. Study Population: newly-admitted, adult mechanically ventilated ICU patients.

Read the detailed description

Study objectives

To evaluate the effect of tight caloric control in critical patients on:

  • The rate of acquired nosocomial infections (Ventilated associated pneumonia, Catheter related infections, Urinary tract infections)
  • Mortality rates, length of stay in the ICU and in hospital, length of ventilation and incidence of non-infectious complications.

Primary endpoint:

Rate of nosocomial infections (for definitions see appendage 1) acquired after 48 to 72 hours following admission.

Secondary endpoints

  • Metabolic control: glucose concentration, insulin administration, rate of hypoglycemic events.
  • Success of tight caloric control: accumulative and maximum negative energy balance.
  • Organ function: SOFA score.
  • Rate of non-infectious complications: requirement for surgery or occurrence of pressure sores.
  • Length of ICU stay and of assisted ventilation (LOS and LOV)
  • ICU survival rate.
  • Patient status and disposition on day 28 or at hospital discharge.
  • 3 \& 6 months survival.
Being tested
Indirect Calorimetry measurement of Resting Energy Expenditure .
Keywords
Enteral Nutrition, Parenteral Nutrition, Indirect Calorimetry, Intravenous Feeding
Medical subject headings
Hyperphagia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Indirect Calorimetry measurement of Resting Energy Expenditure .Dietary supplement

    Patients in this group will receive enteral nutrition/parenteral nutrition or combination of enteral and parenteral nutrition according to the individual energy requirements calculated by Indirect Calorimetry.

Study groups in NCT01479673
Study groupRoleWhat they receive
Control groupNo interventionPatients in this group will receive enteral nutrition/parenteral nutrition or combination of enteral and parenteral nutrition according to the "liberal " regimen, i.e. according to local practice.
Indirect CalorimetryExperimentalStudy group: Indirect Calorimetry (IC) Patients in this group will receive enteral nutrition/parenteral nutrition or combination of enteral and parenteral nutrition according to the individual energy requirements calculated by Indirect Calorimetry measurement of Resting Energy Expenditure (REE).
Receives: Dietary Supplement: Indirect Calorimetry measurement of Resting Energy Expenditure .

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of nosocomial infections

    Rate of nosocomial infections acquired after 48 to 72 hours following admission up to day 28/or discharge will be evaluated

    Measured: After 48 to 72 hours /daily assessment: within 28 day

Secondary outcomes (2)
  1. Metabolic control

    Glucose concentration, insulin administration, rate of hypoglycemic events will be daily assessed

    Measured: Day 1 up to day 28/or discharge

  2. Caloric control

    Success of tight caloric control:accumulative and maximum negative energy balance

    Measured: Day 1 up to day 28/or discharge

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2011 (estimated)
  2. Study startNov 2011
  3. Primary completionDec 2014 (estimated)
  4. Study completionDec 2014 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
560 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01479673
Sponsor's protocol ID
4329
Acronym
P2 -RMCS
Status last verified
Nov 2013
First submitted
22 Nov 2011
Last updated
25 Nov 2013
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Indirect Calorimetry measurement of Resting Energy Expenditure . in people with Mechanical Ventilation Complication, run by Rabin Medical Center at 1 site in Israel.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 25 Nov 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Pierre Singer, MD,Professor (972-3-9376521, psinger@clalit.org.il), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of nosocomial infections (time frame: After 48 to 72 hours /daily assessment: within 28 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Nov 2013.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in